U.S. Department of Health and Human ServicesHHS National Institutes of HealthNIH National Center for Advancing Translational SciencesNCATS
Home

Participate In FDA Advisory Committee Meetings

Overview

U.S. Food and Drug Administration Advisory Committee (FDA Ad Comm) meetings are open to the public. You and your patient community can take part in these meetings by submitting oral or written testimony or attending as an audience member. Your comments may include advising the FDA about benefits or risks of an investigational therapy or discussing the impact of living with your disease.

Resources

FDA Ad Comm Meeting
FDA For Patients Website U. S. Food and Drug Administration (FDA) (link)
Members of an FDA Ad Comm
Applying for Membership on FDA Advisory Committees U. S. Food and Drug Administration (FDA) (link)
Consumer Representatives on FDA Advisory Committees U. S. Food and Drug Administration (FDA) (link)
About the FDA Patient Representative Program U. S. Food and Drug Administration (FDA) (link)
How to Apply to the FDA Patient Representative Program U. S. Food and Drug Administration (FDA) (link)
Providing Testimony
Guidance: The Open Public Hearing at FDA Advisory Committee Meetings U. S. Food and Drug Administration (FDA) (link)
Guidelines for Speakers at the Open Public Hearing of an FDA Advisory Committee Meeting U. S. Food and Drug Administration (FDA) (link)
Tips for Success
What is an Ad Comm? Videorecording Patient Project Muscular Dystrophy (link)
FDA Advisory Committee Meetings: An Overview of the Process & Ways to be Involved Patient Project Muscular Dystrophy (link)
Details & Guidance on Submitting Written Testimony to the FDA Advisory Committee – PPMD Patient Project Muscular Dystrophy (link)
Learn About FDA Advisory Committees U. S. Food and Drug Administration (FDA) (link)
Advisory Committees: Critical to the FDA's Product Review Process U. S. Food and Drug Administration (FDA) (link)
The Open Public Hearing at FDA Advisory Committee Meetings U. S. Food and Drug Administration (FDA) (link)
Public Conduct During FDA Advisory Committee Meetings U. S. Food and Drug Administration (FDA) (link)